AnalystsYigal Nochomovitz
Yigal Nochomovitz's Stock Forecasts

Analyst Ranking
Bottom 3%
#3674 out of 3772 analysts
Average Return
Win Rate
41%28 out of 68
Risk vs Reward

Yigal Nochomovitz's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Zai Lab LtdZLAB
2019-12-30 -
Strong Buy
Loxo Oncology IncLOXO
2017-06-05 -
Strong Buy
Mirati Therapeutics IncMRTX
2018-03-05 -
Strong Buy
Loxo Oncology IncLOXO
2017-11-16 -
Strong Buy
Loxo Oncology IncLOXO
2017-10-20 -
Strong Buy

Yigal Nochomovitz's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Rigel Pharmaceuticals IncRIGL
18 days ago
Aldeyra Therapeutics IncALDX
2Strong Buy$26.00+606.52%Maintains
18 days ago
Shattuck Labs IncSTTK
1Strong Buy$13.00+194.78%Initiates Coverage On
a month ago
Reata Pharmaceuticals IncRETA
5Strong Buy$46.00+48.01%Maintains
a month ago
Ovid Therapeutics IncOVID
a month ago
Oric Pharmaceuticals IncORIC
3Strong Buy$9.00+118.98%Maintains
a month ago
Arvinas IncARVN
2Strong Buy$103.00+124.89%Maintains
a month ago
Applied Therapeutics IncAPLT
1Strong Buy$29.00+3,331.95%Maintains
a month ago
Merus NvMRUS
6Strong Buy$37.00+67.57%Maintains
a month ago
Unity Biotechnology IncUBX
3Strong Buy$5.00+741.75%Maintains
a month ago
Crispr Therapeutics AgCRSP
a month ago
Caribou Biosciences IncCRBU
3Strong Buy$39.00+565.53%Maintains
a month ago
Zai Lab LtdZLAB
2Strong Buy$193.00+464.00%Maintains
2 months ago
Atara Biotherapeutics IncATRA
2 months ago
Ultragenyx Pharmaceutical IncRARE
4Strong Buy$146.00+141.04%Maintains
2 months ago
Zymeworks IncZYME
2Strong Buy$28.00+344.44%Maintains
2 months ago
Mirati Therapeutics IncMRTX
5Strong Buy$208.00+205.16%Maintains
2 months ago
Harpoon Therapeutics IncHARP
3Strong Buy$7.00+236.54%Maintains
3 months ago
Arcturus Therapeutics Holdings IncARCT
3Strong Buy$86.00+432.84%Maintains
3 months ago
Macrogenics IncMGNX
5Strong Buy$21.00+528.74%Upgrades
4 months ago
Galera Therapeutics IncGRTX
1Strong Buy$20.00+1,279.31%Maintains
6 months ago
Ardelyx IncARDX
4Strong Buy$13.00+2,095.95%Maintains
7 months ago
Apellis Pharmaceuticals IncAPLS
2Strong Buy$72.00+55.64%Maintains
7 months ago
Fate Therapeutics IncFATE
1Strong Buy$87.00+224.63%Upgrades
8 months ago
Eiger Biopharmaceuticals IncEIGR
1Strong Buy$27.00+332.69%Maintains
a year ago
Dicerna Pharmaceuticals IncDRNA
a year ago
Syndax Pharmaceuticals IncSNDX
1Strong Buy$24.00N/AInitiates Coverage On
a year ago
Rain Therapeutics IncRAIN
1Strong Buy$28.00N/AInitiates Coverage On
a year ago
Acceleron Pharma IncXLRN
1Strong Buy$171.00N/AMaintains
a year ago
Lexicon Pharmaceuticals IncLXRX
2Strong Buy$6.00N/AUpgrades
2 years ago
Opthea LtdOPT
1Strong Buy$48.00N/AInitiates Coverage On
2 years ago
Cellectis SaCLLS
1Strong Buy$32.00N/AUpgrades
2 years ago
Puma Biotechnology IncPBYI
5Strong Buy$70.00N/AMaintains
3 years ago
Loxo Oncology IncLOXO
6Strong Buy$213.00N/AMaintains
4 years ago
Keryx Biopharmaceuticals IncKERX
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.